MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Pain"

  • 2019 International Congress

    Repetitive transcranial magnetic stimulation (rTMS) for the treatment of pain in Parkinson’s Disease – an open-label study

    M. Bonello, T. Nurmikko, A. Mavrianou, M. Steiger (Liverpool, United Kingdom)

    Objective: To investigate the safety and efficacy of rTMS in the treatment of Parkinson’s Disease associated pain. Background: Pain is a prevalent symptom in patients…
  • 2019 International Congress

    Duloxetine for pain in Parkinsons disease; A single center double blind randomised placebo controlled trial.

    S. Azmin, T. Canento, B. Cruse, S. Sung, M. Farrell, A. Evans (Kuala Lumpur, Malaysia)

    Objective: To determine the efficacy of duloxetine for the management of pain in Parkinsons disease. Background: Presently there are no clear guidelines for the management…
  • 2019 International Congress

    A Dual-Center Study of Pain and Other Non-motor Symptoms in Parkinson disease

    P. Ghosh, P. Imbriani, N. Caputi, L. Covington, A. Sparks, T. Schirinzi, Y. Salnikova, S. Natoli, A. Pisani (Washington Dc, DC, USA)

    Objective: This study aims to explore the relationship between pain and other non-motor symptoms in Parkinson Disease (PD). Background: Pain is a common non-motor symptom…
  • 2018 International Congress

    Predictors and biomarkers of pain in newly diagnosed Parkinson’s disease patients during a two-year follow-up

    S. Perez-Lloret, A. Sauerbier, C. Falup-Percurariu, M. Tinazzi, K.R. Chaudhuri (Buenos Aires, Argentina)

    Objective: To identify clinical characteristics, predictors and biomarkers of pain at baseline and after a two-year follow-up period in newly diagnosed drug-naïve Parkinson's Disease (PD)…
  • 2018 International Congress

    Evaluation of pain in Parkinson’s disease

    B. Durmus, O. Yilmaz Kusbeci, I. Inci (Izmir, Turkey)

    Objective: To determine the prevalence of pain, types and characteristics of pain and the effect of pain on depression and daily living activities in early…
  • 2018 International Congress

    Improvement of Levodopa-Responsive Chronic Pain after STN-DBS in Parkinson’s disease

    A. Gera, G. Pal (Chicago, IL, USA)

    Objective: To illustrate an example of an improvement in chronic pain, following bilateral subthalamic nuclei (STN) deep brain stimulation (DBS) surgery in a Parkinson’s disease…
  • 2018 International Congress

    Sensory signs and neuropathic pain in advanced Parkinson’s disease under levodopa treatment

    A.E. Elia, G. Devigili, M. Damasco, L.M. Romito, P. Soliveri, S. Rinaldo, M. Falsitta, R. Eleopra (Milan, Italy)

    Objective: To evaluate whether patients affected by Parkinson’s disease (PD) under levodopa/carbidopa intestinal gel (LCIG) therapy have alterations in sensory symptoms and signs and/or painful…
  • 2018 International Congress

    The association between pain and physical activity in people with Parkinson’s Disease (PD)

    H. Khalil, A. Al-Sharman, N. Alissa, K. El-Salem, D. Al-Shorafat (Irbid, Jordan)

    Objective: To determine the relationship between pain and physical activity in people with PD Background: Pain in PD is a serious problem that is usually…
  • 2018 International Congress

    Assessment of pain and its correlation with quality of life in Parkinson’s disease

    K. Anand, A. Agrawal, P. Kumar (New Delhi, India)

    Objective: The study was carried out to assess the prevalence of pain, nature of pain, quality of life and correlation of pain with quality of…
  • 2018 International Congress

    Enhanced cingulate activity while anticipating pain – evidence for altered ‘top down’ processing of pain in PD

    S. Martin, A. Jones, C. Brown, C. Kobylecki, M. Silverdale (Manchester, United Kingdom)

    Objective: To investigate the hypothesis that altered ‘top down’ processing contributes to the development of pain in Parkinson’s disease (PD). Background: Altered ‘top down’ processing…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley